QCDR Name,Measure ID,Measure Title,Measure Description ,NQF Number  (if applicable),NQS Domain ,High Priority,Measure Type,Inverse Measure,"Proportional Measure ",Continuous Variable Measure  ,Ratio Measure  ,Number of performance rates to be  submitted                                                  ,Overall Algorithm,Is the Measure Risk-Adjusted   ,Primary Steward,First Performance Year 
AAPM&R's Registry,AAPMR2,Management of Muscle Spasticity--Outpatient,"Percentage of patients, regardless of age with a diagnosis of stroke, acquired brain injury (ABI), spinal cord injury (SCI), cerebral palsy (CP), or multiple sclerosis (MS) with muscle spasticity, who are seen for an office visit during the measurement period with a documented plan of care to monitor and/or manage muscle spasticity",N/A,Effective Clinical Care,No,Process,No,Yes,No,No,1,1st Performance Rate,No,AAPM&R's Registry,2019
AAPM&R's Registry,NPA28,Functional Outcome Assessment for Spine Intervention,"Percentage of patients aged 18 years and older undergoing spine intervention(s) who completed baseline and 3-month follow-up (patient-reported) functional outcome assessment, with at least 10% improvement in the functional status scaled score from the baseline. This measure will be calculated with 2 performance rates:
Rate 1: Patient population with Follow-up/Patient population with baseline
Rate 2: Patient population with improvement in functional status after Follow-up/Patient population with Follow-up. 
Overall Rate = Rate 2",N/A,Person and Caregiver Centered Experience and Outcomes,Yes,Patient Reported Outcome (PRO),No,Yes,No,No,2,2nd Performance Rate,No,Quality Outcomes Database (QOD),2019
GIQuIC,CDR3,Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm OR of 10 years for colonoscopies with only hyperplastic polyp findings in rectum or sigmoid,"Percentage of average-risk patients aged 50 years to 75 years receiving a screening colonoscopy with biopsy or polypectomy and pathology findings of 1 of 2 tubular adenomas < 10 mm with a recommended follow-up interval of not less than 5 years OR pathology findings of only hyperplastic polyp findings in rectum or sigmoid with a recommended follow-up interval of 10 years for repeat colonoscopy documented in their colonoscopy report
Rate 1: 1 to 2 tubular adenomas < 10 mm 
Rate 2: only hyperplastic polyp(s) in rectum or sigmoid",N/A,Efficiency and Cost Reduction,Yes,Process,No,Yes,No,No,2,Weighted Average,No,GIQuIC,2019
H-CPR (Hospitalist -Clinical Performance Registry),HCPR19,30 Day All Cause Readmit Rate for Discharged Inpatients,"Risk-Standardized Rate of All-cause Readmission to the Discharging Hospital and Hospitalist Physician Group within 30 Days of Initial Hospital Discharge
1) Overall 2) Pneumonia 3) CHF 4) COPD.",N/A,Patient Safety,Yes,Outcome,Yes,Yes,No,Yes,4,1st Performance Rate,Yes,H-CPR (Hospitalist -Clinical Performance Registry),2017
